Lumenato™ Receives EFSA Approval, Expanding Market Availability
Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer
May 30, 2024
In a prospective study we evaluated the efficacy of lycopene for the treatment of patients with metastatic hormone refractory prostate cancer.
File Type:
www
Categories:
Lycomato
Continue reading
The FDA and HHS formalizes plans to phase out synthetic colors
On April 22nd, the FDA announced in a press release its intention to phase out petroleum-based synthetic dyes in food, beyond Red 3. While industry actors seem to be divided...
Nature based solutions to replace artificial colors
Consumer awareness of food, health, and other household products is growing and with that, the demand for naturally derived, plant-based colors is soaring.
We're here for you
Interested in speaking directly with a member of our team?
Click below to get in touch.